Distinct medication-state modulation of motor-cortical low-beta power in tremor-dominant and postural instability/gait difficulty Parkinson’s disease: a source-space resting-state EEG study - Report - MDSpire
Advertisement
Distinct medication-state modulation of motor-cortical low-beta power in tremor-dominant and postural instability/gait difficulty Parkinson’s disease: a source-space resting-state EEG study
Differential Effects of Medication on Motor-Cortical Low-Beta Activity in PD
Overview
This study investigates the modulation of motor-cortical low-beta activity in Parkinson's disease subtypes under medication states. It finds significant differences in low-beta power changes between tremor-dominant and postural instability/gait difficulty subtypes when transitioning from OFF to ON medication states, utilizing source-space EEG.
Background
Parkinson's disease (PD) presents with heterogeneous motor symptoms, notably the tremor-dominant (TD) and postural instability/gait difficulty (PIGD) subtypes. Understanding the electrophysiological differences between these subtypes is important. This study utilizes source-space EEG to explore these differences in a controlled medication state.
Data Highlights
Group
Medication State
Low-Beta Power Change (dB)
PIGD
OFF to ON
+1.26 (95% CI [0.48, 2.04])
TD
OFF to ON
-0.20 (95% CI [-1.02, 0.63])
Key Findings
Low-beta relative PSD in the primary motor cortex showed a significant group × state interaction (p = 0.016).
PIGD patients exhibited an increase in low-beta power from OFF to ON medication states.
TD patients showed little change in low-beta power across medication states.
Exploratory analyses indicated differences in high-beta ΔwPLI between cerebellar regions for subtypes (q = 0.028).
No significant network-level effects were identified through NBS.
Clinical Implications
The findings suggest that motor-cortical low-beta activity may serve as a biomarker for distinguishing between PD subtypes in clinical settings. Understanding these differences can inform tailored therapeutic approaches for managing motor symptoms in PD.
Conclusion
This study highlights distinct electrophysiological responses to medication in PD subtypes.